期刊名称：JOURNAL OF NATURAL MEDICINES
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Description
The Journal of Natural Medicines is an international journal presenting original research in naturally occurring medicines and their related foods and cosmetics. It covers
chemistry of natural products; biochemistry of medicinal plants; pharmacology and clinical applications of natural products and herbs, including Kampo formulas and traditional herbs; botanical anatomy; cultivation of medicinal plants.
The journal publishes Reviews, Mini-Reviews, Original Papers, Notes, Rapid Communications and Natural Resource Letters.
Of the papers published in each volume of the Journal of Natural Medicines, approximately three will be chosen by members of the Selection Committee for honors as Excellent Papers.
Abstracted/Indexed in:
Chemical Abstracts Service, ISI Web of Science, Medline, Science Citation Index Expanded
Instructions to Authors
Instructions for authors
Editorial policy
The Journal of Natural Medicines invites papers that make a significant contribution to the knowledge and understanding of naturally occurring medicines and their related foods and cosmetics, including identification and structure elucidation of natural products, biosynthesis, biotechnology, and the clinical application of herbs, natural products, and Kampo formulas to both humans and animals. Papers are also published concerning chemical and botanical identification of herbs or their products where such information contributes to the overall safety of plant-based medicines currently and/or formerly in use. Submission of a paper implies that it has been approved by all the named authors, that it has not been published before, and that it is not under consideration for publication elsewhere. Acceptance of papers will be decided by the Editorial Board after examination by at least two referees. Manuscripts that require revision and/or correction and/or condensation will be returned to the authors with comments specifying alterations from the referees and/or the Editorial Board.The following types of papers may be submitted. (i) Original Papers: Original Papers are the usual form of publication of this journal describing original experimental results. (ii) Notes (up to 4 printed pages): Notes are brief articles reporting new facts and/or valuable data. (iii) Rapid Communications (up to 3 printed pages): These are short preliminary reports of novel and significant findings that merit urgent publication. Full details of the Rapid Communication may be published later as a comprehensive original paper, in this or another journal. An explanatory statement is required for urgent publication. (iv) Reviews (up to 12 printed pages): Reviews covering recent discoveries or topics of current interest are generally invited. (v) Mini-Reviews (up to 6 printed pages): These provide a short overview of a particular subject and are also generally invited. In the case of a non-invited Review or Mini-Review, a short summary describing the outline should be sent to the Editorial Office for approval before submitting a manuscript. (vi) Natural Resource Letters: Natural Resource Letters are reports on biological screening data, field observations, market surveys, quality evaluation or quantitative methods of crude drugs, etc., which may contribute to the scientific knowledge of the readers.
Manuscript submission
Papers in triplicate (one original and two photocopies) should be sent by registered mail to the Editorial Office.In the cover letter, the type of paper, an e-mail address, and fax number should be noted. Electronic data should not be sent to the publisher until the manuscript has been reviewed and accepted for publication.Chief EditorEditorial Office of the Journal of Natural Medicinesc/o Center for Academic Publications Japan4-16, Yayoi 2-chome, Bunkyo-ku, Tokyo, 113-0032 JapanTel: +81-3-3817-5821; Fax: +81-3-3817-5830e-mail address: j-natmed@capj.or.jp
Legal requirements
The author(s) guarantee(s) that the manuscript will not be published elsewhere in any language without the consent of The Japanese Society of Pharmacognosy and Springer, that the rights of third parties will not be violated, and that the publisher will not be held legally responsible should there be any claims for compensation.Authors wishing to include figures or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.The "Copyright Transfer Statement" has to be signed and faxed to the publisher together with the corrected proofs with which it will be provided by the publisher shortly after the manuscript has been accepted for publication.
Manuscript preparation
Manuscripts must be written in English using Times font and typed in double-line spacing with 3-cm margins; pages should be numbered. Authors whose first language is not English are urged to have their manuscript read by a colleague who is a native English speaker and is familiar with their field of work before submitting the paper.Manuscripts with extensive English language deficiencies will be returned to the author without the full reviewing process.
|
Japanese abstractJapanese authors are requested to submit an abstract in Japanese (200-300 characters) in a file separate from their English manuscript. This Japanese abstract will be printed with a collection of other abstracts in "Shoyakugaku Zasshi". In case neither of the authors is a native speaker of Japanese, the authors are exempted from this request, and the editorial board will make a translation of the abstract. In any case, authors are not requested to proofread the Japanese abstract. |
|
Documentation of experimental biological materials. Use the correct scientific name and indicate who identified the biological materials. The herbarium deposit site and voucher number should be recorded. Authors who purchase herbal materials from companies must make provision for their deposit in a herbarium. |
|
Pharmacological investigations of extracts require detailed extract characterization. This includes botanical characterization of plant material(s), solvent(s), duration and temperature of extraction, plus other method(s) used for preparation(s). A chromatographic (e.g., HPLC profile recorded at different wavelengths) or chemical characterization (quantities of typical constituents) must be presented. The investigation must clearly indicate a dose/activity dependence in comparison with a reference compound (positive control) together with the appropriate statistics. | The manuscript should be arranged as follows:
Text of the paper: Introduction; main text (divided into sections, if appropriate); Acknowledgments; References; tables; figure legends
|
Abbreviations. Abbreviations must be spelled out in full at their initial appearance in the abstract and main text, followed by the abbreviation in parentheses. Thereafter, the abbreviation may be employed.However, the following need not be defined : AIDS (acquired immunodeficiency syndrome), ATP (adenosine 5'-triphosphate), cAMP (adenosine 3',5'-cyclic monophosphate), CD (circular dichroism), cDNA (complementary DNA), CoA (coenzyme A), COSY (correlated spectroscopy), DNA (deoxyribonucleic acid), ED50 (50% effective dose), EI-MS (electron ionization mass spectrometry), FAB-MS (fast atom bombardment mass spectrometry), FAD (flavin adenine dinucleotide), GC-MS (gas chromatography-mass spectrometry), HMBC (heteronuclear multiple bond connectivity), HMQC (heteronuclear multiple quantum coherence), HPLC (high-pressure liquid chromatography, high-performance liquid chromatography), HSQC (heteronuclear single quantum coherence), IC50 (inhibitory concentration, 50%), IR (infrared), LD50 (50% lethal dose), mRNA (messenger RNA), MS (mass spectrum), NMR (nuclear magnetic resonance, as 13C-NMR, 1H-NMR), NOE (nuclear Overhauser effect), NOESY (nuclear Overhauser and exchange spectroscopy), ORD (optical rotatory dispersion), P450 (as in cytochrome P450), RNA (ribonucleic acid), rRNA (ribosomal RNA), TLC (thin-layer chromatography), tRNA (transfer RNA), UV (ultraviolet). |
|
Units. The following units should be used: length (m, cm, mm, μm, nm, Å), mass (kg, g, mg, μg, ng, pg, mol, mmol), volume (l, ml, μl), time (s, min, h, d), temperature (°C, K), radiation (Bq, Ci, dpm, Gy, rad), concentration (M, mM, mol/1, mmol/1, mg/ml, μg/ml, %, %(v/v), % (w/v), ppm, ppb). |
|
Spectral and elemental analysis data. Please report spectral and elemental analysis data in the following format, 1H-NMR (CDCl3) δ:1.25 (3H, d, J=7.0 Hz), 3.55 (1H, q, J=7.0 Hz), 6.70 (1H, m). 13C-NMR (CDCl3) δ:20.9 (q), 71.5 (d), 169.9 (s). IR (KBr) cm-1: 1720, 1050, 910. UV λmax(H2O) nm (log ε):280 (3.25). MS m/z :332 (M+), 180, 168. HRFAB-MS m/z:332.1258 (Calcd for C18H20O6: 332.1259). [α]D23—74.5° (c 1.0, MeOH). Anal. Calcd for C19H21NO3:C, 73.29; H, 6.80; N, 4.50. Found: C, 73.30; H, 6.88; N, 4.65. |
|
Nomenclature. The nomenclature of chemical compounds should be in accordance with the nomenclature rules formulated by IUPAC. Alternatively, naming may conform to the nomenclature in the index of Chemical Abstracts or the Ring Index. |
|
X-ray crystal structure analyses. When structure determination by X-ray crystallographic analysis is a central theme of the paper, the data required for registration with the Cambridge Crystallographic Data Base (CCDB) should be attached as supplementary material. Although this does not apply in cases where crystallographic analysis plays only a supplementary role, crystal data (unit cell parameters, space group, Z density) and R-factor should still be noted. Atomic coordinates, bond lengths and angles, thermal parameters, and torsion angles should be presented when they are important for the issues addressed in the paper. When papers have been accepted, the authors are advised to register the data with CCDB. |
References
The list of References should include only works that are cited in the text and that have been published or accepted for publication. Personal communications should be mentioned only in the text. If available, the DOI can be added at the end of the reference in question.References should be numbered in the order in which they appear in the text and be listed in numerical order. Journal titles should be abbreviated according to Chemical Abstracts. References should be styled as follows, with correct punctuation: 1. Kuroyanagi M, Umehara K, Hayashi T, Hirayama Y (2002) Cell differentiation inducers and antiandrogenic active compounds from zingiberis rhizoma. Nat Med 56:47–502. Chen W, Punja Z (2002) Agrobacterium-mediated transformation of American ginseng with a rice chitinase gene. Plant Cell Rep 20:1039–1045 DOI 10.1007/s00299-002-0446-z3. Tsukaya H, Iokawa Y, Kondo M, Ohba H (2005) Large-scale general collection of wild-plant DNA in Mustang, Nepal. J Plant Res DOI 10.1007/s10265-005-0196-44. Capasso F, Gaginella TS, Grandolini G., Izzo AA (2003) Phytotherapy. Springer, Berlin Heidelberg New York5. Bauer BA (2003) Herbal therapy and the elderly. In: Cherniack P, Cherniack N (eds) Alternative medicine for the elderly. Springer, Berlin Heidelberg New York, pp 111–132
Tables and figures
All figures (photographs, graphs or diagrams) and tables should be cited in the text, and each should be numbered consecutively throughout with arabic numerals. All artwork must be provided in the actual size that they are to appear (single-column width is 8.4 cm; double-column width is 17.4 cm). Single-column artwork is recommended. The publisher reserves the right to reduce or enlarge illustrations.Tables must be numbered consecutively with arabic numerals. They should have a title explaining any abbreviation used in that table. Footnotes to tables should be indicated by superscript lowercase letters (or asterisks for significance values and other statistical data). Illustrations must be restricted to the minimum needed to clarify the text. All figures (photographs, graphs, or diagrams) should be cited in the text, and numbered consecutively throughout. Figure parts should be identified by lowercase roman letters (a, b, etc.). If illustrations are supplied with uppercase labeling, lowercase letters will still be used in the figure legends and citations. Figure legends must be brief, self-sufficient explanations of the illustrations. The legends should be placed at the end of the text. All figures should be submitted as separate files and should not be integrated within the text. The preferred figure formats are EPS (Encapsulated Postscript) for vector graphics exported from a drawing program and TIFF for halftone illustrations. EPS files must always contain a preview in TIFF of the figure. Microsoft PowerPoint files and illustrations embedded in Microsoft Word documents are not acceptable. The file name should include the figure number.
|
Line drawings. Inscriptions should be legible, with initial capital letters and appropriately scaled to the size of the drawing. Scanned line drawings should be digitized with a resolution of 800 dpi relative to the final figure size. |
|
Halftone illustrations (black and white and color). Magnification should be indicated by scale bars. For scanned halftone illustrations, a resolution of 300 dpi is usually sufficient. |
|
Color figures will always be published in color in the online version. In print, however, they will appear in color only if the author agrees to make a contribution (JPY 110 000 for the first and JPY 60 000 for each additional page) to printing costs. Otherwise the figures will be printed in black and white. Please note that, in such cases, it is authors’ responsibility to prepare figures to be illustrative enough to convey the necessary information even after they are converted into black and white. |
|
Color illustrations should be saved as RGB (8 bits per channel) in TIFF format. | The manuscripts and the figures will not normally be returned, unless specifically requested by the authors.
Conflict-of-interest policy
Authors should indicate any financial assistance, commercial affiliations, or potential conflicts of interest associated with any work submitted for publication.
Ethical Standards
Manuscripts that reveal a lack of ethical consideration for human subjects or experimental animals will not be accepted for publication. All clinical research using human subjects or materials should be conducted in accordance with the Recommendations from the Declaration of Helsinki. For animal experiments, authors should follow the guidelines for the care and use of laboratory animals approved by the Japanese Pharmacological Society (http://plaza.umin.ac.jp/JPS1927/jps/Animal.pdf). Authors must also indicate in a cover letter and/or the manuscript that the research was conducted in accordance with the Declaration of Helsinki and with the guidelines for the care and use of laboratory animals approved by the Japanese Pharmacological Society.
Manuscripts in electronic form
After acceptance, the electronic version of the manuscript should be sent to the Editorial Office along with a printout of the whole manuscript.Authors should follow the technical instructions for manuscripts and illustrations in electronic form.Files should be saved in the following formats:
Electronic Supplementary Material
Electronic Supplementary Material (ESM) for a paper will be published in the electronic edition of this journal provided the material is:
ESM may consist of:information that cannot be printed: animations, video clips, sound recordings (use QuickTime, .avi, .mpeg, animated GIFs, or any other common file format); information that is more convenient in electronic form: sequences, spectral data, etc.; large quantities of original data that relate to the paper, e.g., additional tables, large numbers of illustrations (color and black & white), etc. Legends must be brief, self-sufficient explanations of the ESM. ESM is to be numbered and referred to as S1, S2, etc.After acceptance for publication, ESM will be published as received from the author in the online version only. Reference will be given in the printed version.
Proofs, offprints, and page charges
|
Proofs. Authors are informed by e-mail that a temporary URL has been created from which they can obtain their proofs. Proofreading is the responsibility of the author. Authors should make their proof corrections (formal corrections only) on a printout of the pdf file supplied, checking that the text is complete and that all figures and tables are included. Substantial changes in content, e.g., new results, corrected values, title, and authorship, are not allowed without the approval of the responsible editor. In such a case the Editorial Office should be contacted before the proofs are returned to the publisher. After online publication, corrections can be made only in exceptional cases and in the form of an Erratum, which will be hyperlinked to the paper. |
|
Online First. Papers will be published online about one week after receipt of the corrected proofs. Papers published online can be cited by their DOI immediately. After release of the printed version, the paper can also be cited by issue and page numbers. |
|
Offprints. Twenty-five (25) offprints of each contribution are supplied free of charge. To order additional offprints, the order form provided with the proofs should be returned together with the corrected proofs. |
|
Page charges. The following charges are to be paid within one month after publication of a paper.(i) Handling charges: JPY 4,000 per printed page. These charges are waived if the corresponding author’s affiliation is with an institution or organization located outside of Japan. (ii) Charges for excess pages in Notes and Rapid Communications: JPY 8,000 per printed page in addition to the handling charges. |
Open Choice
In addition to the normal publication process (whereby an article is submitted to the journal and access to that article is granted to customers who have purchased a subscription), Springer now provides an alternative publishing option: Springer Open Choice. A Springer Open Choice article receives all the benefits of a regular “subscription-based” article, but in addition is made available publicly through Springer's online platform SpringerLink. To publish via Springer Open Choice, upon acceptance for publication, the author can visit www.springeronline.com/openchoice to complete the relevant order form and provide the required payment information. Payment must be received in full before publication, or articles will be published as regular subscription-model articles. We regret that Springer Open Choice cannot be ordered for published articles.(Revised 19 May 2008)
Date of issue
The journal will be issued on 10th of January, April, July, and October each year.
Editorial Board
Editorial Board
Chief Editor
Hiromitsu Takayama
Chiba University, Chiba, Japan
Associate Editors
Fumiyuki Kiuchi
National Institute of Biomedical Innovation, Ibaraki, Japan
Hisashi Matsuda
Kyoto Pharmaceutical University, Kyoto, Japan
Editors
Sjamsul Arifin Achmad
Institute Technology Bandung, Bandung, Indonesia
Shao-Qing Cai
Peking University, Beijing, China
Syunji Horie
Josai International University, Chiba, Japan
Makoto Inoue
Aichi Gakuin University School of Pharmacy, Nagoya, Japan
Michiho Ito
Kyoto University, Kyoto, Japan
Junei Kinjo
Fukuoka University, Fukuoka, Japan
Junichi Kitajima
Showa Pharmaceutical University, Tokyo, Japan
Hiroaki Kiyohara
Kitasato University, Tokyo, Japan
Jun'ichi Kobayashi
Hokkaido University, Sapporo, Japan
Hiroshi Kohda
Hiroshima University, Hiroshima, Japan
Katsuko Komatsu
Toyama University, Toyama, Japan
Marie Aleth Lacaille-Dubois
University of de Burgundy, Dijon, France
Yutaka Orihara
The University of Tokyo, Tokyo, Japan
Eiji Sakai
Gifu Pharmaceutical University, Gifu, Japan
Hirotaka Shibuya
Fukuyama University, Fukuyama, Japan
Yukihiro Shoyama
Kyushu University, Fukuoka, Japan
Kunio Takahashi
Meiji Pharmaceutical University, Tokyo, Japan
Tadahiro Takeda
Keio University Faculty of Pharmacy, Tokyo, Japan
Kazuo Toriizuka
Showa University, Tokyo, Japan
LingLing Yang
Taipei Medical University, Taipei, Taiwan (R.O.C.)
Chun-Su Yuan
The University of Chicago, Chicago, Ill., USA
|
刊名字顺( Alphabetical List of Journals):
返回页首 